Enanta Pharmaceuticals (ENTA) Q2 2024 Earnings

6MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-2.33
-1.96
-1.59
-1.23

Details

Expected EPS
-1.33625
Actual EPS
-1.47
Surprise EPS
-0.13
Surprise Percent
+10.01%

Description

Enanta Pharmaceuticals (ENTA) has reported earnings of -1.47 per share for Q2 2024.

0 Comments

Share your thoughts